Founded by the Italian Government as international private-public partnership, its mission is to develop biotechnological and biomedical translational research approaches, disseminate scientific knowledge and train qualified professionals in the Life Science sector. Translational research is focused on basic research, preclinical research and development of new therapies, medical devices and biomarkers, and finally clinical trial. For the nature of the founding partners, as CNR, the University of Pittsburgh and UPMC, the Foundation has developed translational research programs. With the partnership with ISMETT, RiMED’s fostered multidisciplinary projects in reg med and cellular therapies including a GMP cell factory to support clinical trial. The research in Ri.MED follows 3 main approaches: bio-engineering, drug discovery and vaccine development, and regenerative medicine, focusing on therapeutic areas as oncology, aging, neurodegeneration, infectious and organ failure diseases.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):